UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors

Proceedings of the National Academy of Sciences - PNAS, 2015-08, Vol.112 (32), p.E4410-E4417

2015

Volltextzugriff (PDF)

Obinutuzumab-atezolizumab-lenalidomide for the treatment of patients with relapsed/refractory follicular lymphoma: final analysis of a Phase Ib/II trial

Blood cancer journal (New York), 2021-08, Vol.11 (8), p.147-147, Article 147

2021

Volltextzugriff (PDF)

Immune Characteristics of Chinese Diffuse Large B-Cell Lymphoma Patients: Implications for Cancer Immunotherapies

EBioMedicine, 2018-07, Vol.33, p.94-104

2018

Volltextzugriff (PDF)

Rfm1, a Novel Tethering Factor Required To Recruit the Hst1 Histone Deacetylase for Repression of Middle Sporulation Genes

Molecular and Cellular Biology, 2003-03, Vol.23 (6), p.2009-2016

2003

Volltextzugriff (PDF)

Molecular Determinants of Response to Mosunetuzumab Plus CHOP in Patients with Previously Untreated (1L) Diffuse Large B Cell Lymphoma (DLBCL)

Blood, 2023-11, Vol.142 (Supplement 1), p.2999-2999

2023

Volltextzugriff (PDF)

SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-κB-Dependent Gene Expression and Organismal Life Span

Cell, 2009-01, Vol.136 (1), p.62-74

2009

Volltextzugriff (PDF)

Swapping the Gene-Specific and Regional Silencing Specificities of the Hst1 and Sir2 Histone Deacetylases

Molecular and Cellular Biology, 2007-04, Vol.27 (7), p.2466-2475

2007

Volltextzugriff (PDF)

Detection of Early Molecular Response (EMR) and Minimal Residual Disease (MRD) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Using a Validated Next Generation Sequencing (NGS) Assay for the Detection of Tumor Variants in Circulating Tumor (ct)DNA

Blood, 2022-11, Vol.140 (Supplement 1), p.9257-9258

2022

Volltextzugriff (PDF)

Identification of Target Sites of the α2–Mcm1 Repressor Complex in the Yeast Genome

Genome research, 1999-11, Vol.9 (11), p.1040-1047

1999

Volltextzugriff (PDF)

Single-Agent Mosunetuzumab Is a Promising Safe and Efficacious Chemotherapy-Free Regimen for Elderly/Unfit Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

Blood, 2020-11, Vol.136 (Supplement 1), p.43-45

2020

Volltextzugriff (PDF)

CBP/p300 Drives the Differentiation of Regulatory T Cells through Transcriptional and Non-Transcriptional Mechanisms

Cancer research (Chicago, Ill.), 2019-08, Vol.79 (15), p.3916-3927

2019

Volltextzugriff (PDF)

Pharmacodynamic Effects and Immune Correlates of Response to the CD20/CD3 Bispecific Antibody Mosunetuzumab in Relapsed or Refractory Non-Hodgkin Lymphoma

Blood, 2019-11, Vol.134 (Supplement_1), p.1585-1585

2019

Volltextzugriff (PDF)

ABCL-366: Mosunetuzumab (Mosun) Monotherapy for Elderly/Unfit Patients with First-Line Diffuse Large B-Cell Lymphoma (DLBCL) Continues to Show Promising Safety and Efficacy with Durable Complete Responses

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S395-S396

2021

Volltextzugriff (PDF)

Poster: ABCL-366: Mosunetuzumab (Mosun) Monotherapy for Elderly/Unfit Patients with First-Line Diffuse Large B-Cell Lymphoma (DLBCL) Continues to Show Promising Safety and Efficacy with Durable Complete Responses

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S239-S239

2021

Volltextzugriff (PDF)

Abstract 462: Chromatin signatures of DLBCL subtypes

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.462-462

2014

Volltextzugriff (PDF)

Abstract 555: DNA methylation patterns are associated with subpopulations of diffuse large B-cell lymphoma

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.555-555

2014

Volltextzugriff (PDF)

Abstract 1430: Identification of distinct metabolic subtypes within pancreatic ductal adenocarcinoma through broad metabolite profiling

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.1430-1430

2014

Volltextzugriff (PDF)

SIRT6 links histone H3 lysine 9 deacetylation to control of NF-κB dependent gene expression and organismal lifespan

Cell, 2009-01, Vol.136 (1), p.62-74

2009

Volltextzugriff (PDF)

VIEWPOINT: Risk-Retention Bill Misdirected

The American banker, 2010-03, Vol.175 (38), p.8-8

McCord, Ron

2010

Volltextzugriff (PDF)

VIEWPOINT: Mortgage Reform Plans Fail to Look Forward

The American banker, 2009-10, Vol.174 (F309), p.8-8

McCord, Ron

2009

Volltextzugriff (PDF)

SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span

Cell, 2009-01, Vol.136 (1), p.62-74

2009

Volltextzugriff (PDF)

Bright ideas from future leaders

Mortgage banking, 1997-12, Vol.57 (3), p.68

McCord, Ron

1997

Volltextzugriff (PDF)

A class of future leaders

Mortgage banking, 1997-08, Vol.57 (11), p.44

McCord, Ron

1997

Volltextzugriff (PDF)

Bright ideas from future leaders

Mortgage banking, 1997-12, Vol.58 (3), p.68

McCord, Ron J

1997

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(24)

Publikationsform

Sprache

Englisch
(29)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(10)
Life Sciences & Biomedicine
(6)
Humans
(4)
Biochemistry & Molecular Biology
(3)
Cell Biology
(3)
Mortgage Banks
(3)
Sirtuins - Metabolism
(3)
Acetylation
(2)
Banking Industry
(2)
Dlbcl
(2)
Engineering
(2)
Engineering, Electrical & Electronic
(2)
Executives
(2)
Gene Silencing
(2)
Government Regulation
(2)
Histone Deacetylases - Metabolism
(2)
Immunotherapy
(2)
Laws, Regulations And Rules
(2)
Leadership
(2)
Mathematical Models
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(5)
Cancer Research
(4)
Cell
(3)
Mortgage Banking
(3)
Clinical Lymphoma, Myeloma And Leukemia
(2)
Molecular And Cellular Biology
(2)
The American Banker
(2)
Blood Cancer Journal
(1)
Ebiomedicine
(1)
Genome Research
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors

Obinutuzumab-atezolizumab-lenalidomide for the treatment of patients with relapsed/refractory follicular lymphoma: final analysis of a Phase Ib/II trial

Immune Characteristics of Chinese Diffuse Large B-Cell Lymphoma Patients: Implications for Cancer Immunotherapies

Rfm1, a Novel Tethering Factor Required To Recruit the Hst1 Histone Deacetylase for Repression of Middle Sporulation Genes

Molecular Determinants of Response to Mosunetuzumab Plus CHOP in Patients with Previously Untreated (1L) Diffuse Large B Cell Lymphoma (DLBCL)

SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-κB-Dependent Gene Expression and Organismal Life Span

Swapping the Gene-Specific and Regional Silencing Specificities of the Hst1 and Sir2 Histone Deacetylases

Detection of Early Molecular Response (EMR) and Minimal Residual Disease (MRD) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Using a Validated Next Generation Sequencing (NGS) Assay for the Detection of Tumor Variants in Circulating Tumor (ct)DNA

Glofitamab (Glofit) Plus R-CHOP Has a Favorable Safety Profile and Induces High Response Rates in Patients with Previously Untreated (1L) Large B-Cell Lymphoma (LBCL) Defined As High Risk By Circulating Tumor DNA (ctDNA) Dynamics: Preliminary Safety and Efficacy Results

Identification of Target Sites of the α2–Mcm1 Repressor Complex in the Yeast Genome

Single-Agent Mosunetuzumab Is a Promising Safe and Efficacious Chemotherapy-Free Regimen for Elderly/Unfit Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

CBP/p300 Drives the Differentiation of Regulatory T Cells through Transcriptional and Non-Transcriptional Mechanisms

Pharmacodynamic Effects and Immune Correlates of Response to the CD20/CD3 Bispecific Antibody Mosunetuzumab in Relapsed or Refractory Non-Hodgkin Lymphoma

ABCL-366: Mosunetuzumab (Mosun) Monotherapy for Elderly/Unfit Patients with First-Line Diffuse Large B-Cell Lymphoma (DLBCL) Continues to Show Promising Safety and Efficacy with Durable Complete Responses

Poster: ABCL-366: Mosunetuzumab (Mosun) Monotherapy for Elderly/Unfit Patients with First-Line Diffuse Large B-Cell Lymphoma (DLBCL) Continues to Show Promising Safety and Efficacy with Durable Complete Responses

Abstract 462: Chromatin signatures of DLBCL subtypes

Abstract 555: DNA methylation patterns are associated with subpopulations of diffuse large B-cell lymphoma

Abstract 1430: Identification of distinct metabolic subtypes within pancreatic ductal adenocarcinoma through broad metabolite profiling

SIRT6 links histone H3 lysine 9 deacetylation to control of NF-κB dependent gene expression and organismal lifespan

VIEWPOINT: Risk-Retention Bill Misdirected

VIEWPOINT: Mortgage Reform Plans Fail to Look Forward

SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span

Bright ideas from future leaders

A class of future leaders

Bright ideas from future leaders

Suchergebnisse filtern